Survey on measures for hepatitis B and C in liver specialty hospitals other than regional core centers

DOI Web Site Web Site 2 References
  • Inoue Taisuke
    Nirasaki City Hospital Department of Gastroenterology and Hepatology, University of Yamanashi Hospital
  • Ide Tatsuya
    Kurume University Hospital, Fukuoka Consulting and Support Center for Liver Disease
  • Uchida Yoshihito
    Department of Gastroenterology and Hepatology, Saitama Medical University Hospital
  • Ogawa Koji
    Department of Gastroenterology and Hepatology, Hokkaido University Hospital
  • Inoue Takako
    Department of Clinical Laboratory Medicine, Nagoya City University Hospital
  • Suetsugu Atsushi
    Department of Gastroenterology/Internal Medicine, Gifu University Hospital
  • Ikegami Tadashi
    Division of Gastroenterology and Hepatology, Tokyo Medical University Ibaraki Medical Center
  • Setoyama Hiroko
    Department of Gastroenterology and Hepatology, Kumamoto University Hospital
  • Inoue Jun
    Department of Gastroenterology, Tohoku University Hospital
  • Kakizaki Satoru
    Department of Clinical Research, National Hospital Organization Takasaki General Medical Center
  • Enomoto Masaru
    Department of Hepatology, Osaka Metropolitan University Hospital
  • Tatsuki Sachiko
    Department of Nursing, Tokushima University Hospital
  • Endo Mizuki
    Department of Gastroenterology, Oita University Hospital
  • Nagata Kenji
    Department of Gastroenterology and Hepatology, University of Miyazaki Hospital
  • Korenaga Masaaki
    Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine

Bibliographic Information

Other Title
  • 拠点病院以外の肝疾患専門医療機関における院内肝炎ウイルス陽性者対策調査
  • キョテン ビョウイン イガイ ノ カン シッカン センモン イリョウ キカン ニ オケル インナイ カンエンウイルス ヨウセイシャ タイサク チョウサ

Search this article

Abstract

<p>This study was conducted in 2021, wherein we investigated in-hospital measures for patients positive for hepatitis virus in 288 hospitals specializing in liver diseases in 13 Japanese prefectures. Our results showed that even at specialty hospitals, the overall countermeasure implementation rate was low (56%). The rate was higher in hospitals that had a higher bed capacity (>400), more full-time hepatologists, and more hepatitis medical care coordinators. Of these three factors, implementation rate was most influenced by coordinator enrollment, with highest involvement by clinical laboratory technologists. Therefore, clinical laboratory technologists should be trained to improve countermeasure rates for both treatment of liver disease and safety management in hospitals. Furthermore, the improvement in the implementation rate of measures for patients positive for hepatitis virus will help in providing better treatment.</p>

Journal

  • Kanzo

    Kanzo 64 (12), 649-652, 2023-12-01

    The Japan Society of Hepatology

References(2)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top